Goldtrack Ventures has announced the launch of a new USD 250 million industrial biotechnology growth fund based in Saudi Arabia. The initiative, revealed at the Global Health Exhibition in Riyadh, is set to significantly advance the Kingdom’s innovation ecosystem by focusing on scaling high-potential biotech enterprises both locally and across the MENA region.
A Strategic Focus on Industrial Biotechnology
The fund will direct its capital towards a wide spectrum of biotechnology sectors, including red (medical), green (agricultural), white (industrial), yellow (food), grey (environmental), blue (marine), and golden (bioinformatics). A key priority will be placed on companies with industrial applications, particularly in bio-based materials, agri-tech, and sustainable solutions that align with Saudi Arabia’s national development priorities. This targeted approach aims to translate scientific breakthroughs into commercially viable and scalable ventures.
Fund Timeline and Regulatory Path
Goldtrack Ventures is currently structuring the fund and intends to file it with Saudi Arabia’s Capital Market Authority (CMA) by late 2025. The firm anticipates making its initial investments in 2026. By leveraging its team’s extensive expertise in international fund management and scientific research, the fund is positioned to identify and nurture leading biotech companies prepared for significant growth.
Fostering a Regional Innovation Hub
Beyond providing capital, the fund aims to catalyze a vibrant ecosystem by fostering collaborations between academic institutions, industrial partners, and innovators. The goal is to create a hub that not only scales Saudi enterprises but also attracts international companies to the region. “Along with the accelerating growth of digital ecosystems, we are building vibrant and industrial ecosystems – systems that will redefine how industries grow, produce, and sustainably thrive,” said Mark Rayner, Managing Partner at Goldtrack Ventures.
About Goldtrack Ventures
GOLDTRACK Ventures GmbH is a European-based investment and advisory firm specializing in biotechnology and sustainable industrial innovation. The firm’s team has a proven track record in venture capital and entrepreneurship, focusing on connecting science, capital, and strategic partnerships to scale businesses that redefine industries and contribute to a more sustainable future.
Source: Waya
